On July 20, clinicians at UNC Health Southeastern’s Gibson Cancer Center administered the first dose of a highly sought-after prostate cancer fighting drug…
Prophylactic radiotherapy for asymptomatic bone metastases could become standard of care after a randomized trial showed that it improved overall survival as well as reducing skeletal-related events.